ArticleFrontiers in immunology2026

Noncanonical NF-κB pathway driven inflammation across multiple cellular compartments identifies NIK as a therapeutic target for inflammatory bowel disease.

Hao Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.